That's right, I struggle to find potential revenue for AT1 except for the FDA approval for Febridx. Other new products would take a lot more time with the way AT1 gets regulatory approvals.
speaking of Febridx, man, LDX has been brutal lol. I should not get back in after I took a tiny loss with my first entry. Got back in at 70cent then 56 cents, now is close to 30 cents. In such a short period and it is a straight line down, not even able to trade it to cover some loss
I guess I made the same mistake there like AT1 is to putting bets on a concept rather than waiting till it comes to fruition. Lesson's learned.
AT1 Price at posting:
11.8¢ Sentiment: Sell Disclosure: Not Held
